Linera M 2.5/850 mg is an oral antidiabetic combination medication used in the management of type 2 diabetes mellitus (T2DM). It contains Linagliptin, a DPP-4 inhibitor, and Metformin, a first-line biguanide. This combination helps improve glycemic control in adults when diet and exercise alone are insufficient.